Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease

Circulation

Volumn 102, Issue 16, 2000, Pages 1917-1923

  Muhlestein, Joseph B ^a,b   Horne, Benjamin D ^a   Carlquist, John F ^a,b   Madsen, Troy E ^a   Bair, Tami L ^a   Pearson, Robert R ^a   Anderson, Jeffrey L ^b  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Antibodies; Coronary disease; Follow up studies; Risk factors; Survival

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SERODIAGNOSIS; THROMBOGENESIS;

EID: 0034680353     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.16.1917     Document Type: Article

References (36)

1. Dyslipidemia and other risk factors for coronary artery disease
2. Shattuck lecture: Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
3. Atherosclerosis: An inflammatory disease
4. Cell biology of atherosclerosis
5. Cite of intimal rupture or erosion of thrombosis coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
6. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: Potential role of matrix-degrading metalloproteinases and implications for plaque rupture
7. Inflammation: Atherosclerosis and ischemic events: Exploring the hidden side of the moon
8. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction
9. C-reactive protein concentration in myocardial infarct patients with a closed versus an open infarct related coronary artery after thrombolytic therapy
10. Production of C-reactive protein and risk of coronary events in stable and unstable angina
11. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
12. Hemostatic factors in the risk of myocardial infarction or sudden death in patients with angina pectoris
13. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
14. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
15. Oxidized LDL and atherogenesis
16. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
17. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart Study
18. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease
19. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979
20. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
21. Increased incidence of Chlamydia species within the coronary arteries of patients with severe atherosclerosis versus other forms of cardiovascular disease
22. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis
23. Chlamydia in atherosclerosis
24. Possible role of cytomegalovirus in atherogenesis
25. Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation
26. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy
27. Relation of Helicobacter pylori infection and coronary heart disease
28. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors
29. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial
30. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
31. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
32. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
33. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project
34. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke
35. Cytomegalovirus in the pathogenesis of atherosclerosis: The role of inflammation as reflected by elevated C-reactive protein levels